Emerging Materials Influence Global Vaccine Packaging: Technology Opportunity Analysis

1.1 Why Is It Increasingly Difficult to Grow?

1.2 The Strategic Imperative 8™

1.3 The Impact of the Top Three Strategic Imperatives on Materials for Vaccine Packaging

1.4 About the Growth Pipeline Engine™

1.5 Growth Opportunities Fuel the Growth Pipeline Engine™

1.6 Research Methodology

2.1 Research Context

2.2 Research Scope: Key Questions the Research Will Answer

2.3 The Need for Better Vaccine Packaging Materials

2.4 Industrial Needs Influencing Research Efforts in Vaccine Packaging Materials

2.5 The Various Materials Being Researched for Replacing Traditional Packaging Materials

2.6 Smart Packaging Opportunities in the COVID-19 Vaccine Supply Chain

3.1 The Needs and Requirements of Vaccine Packaging

3.2 COVID-19 Vaccine Packaging Requirements and Efforts to Overcome the Challenges

3.3 Trends Impacting R&D in Vaccine Packaging in North America (NA) and Europe

3.4 Trends Impacting R&D in Vaccine Packaging in Asia-Pacific (APAC) and the Middle East

3.5 Factors Influencing Material Selection and Adoption

3.6 Current Trends Influencing Vaccine Packaging Materials’ R&D and Adoption

3.7 Emerging Trends Influencing the Adoption of Materials for Vaccine Packaging

4.1 The Various Materials Explored for Use in Vaccine Packaging

4.2 Recycled Materials and Polymers Being Tested for Use in Secondary Packaging

4.3 Aluminosilicate Glass for Manufacturing Vials Gaining Prominence Due to Its High Mechanical Strength

4.4 Increasing Demand for Transparent Polymers Enabling the Use of COC for Vaccine Packaging

4.5 High-purity Quartz Vials as Potential Alternative to Type-1 Borosilicate Glass Vials

4.6 Hybrid Vials Manufactured Using Polymers and Glass Nanocoatings Offer Effective Barrier Properties

4.7 Bio-derived EPS for Secondary and Tertiary Packaging Improves Environmental Profile

4.8 Fluoropolymers Can Offer Improved Stability and Shelf Life as Compared to Glass Vials

4.9 Thin Surfactant-stabilized Cellulose Matrix FilmsUndergoing Research for Storing Vaccines and Biologics

4.10 PCMs Being Considered for Vaccine Packaging Due to Their High Latent Heat Properties

4.11 Coated Folding Boxboard from Renewable Fibers Being Used for Vaccine Bottles and Injectors

4.12 Carbon-neutral and Recyclable Biopolymers of Interest to the Pharmaceutical Industry

4.13 Post-consumer Recycled PET as Secondary Vaccine Packaging Materials

5.1 Companies in the United States Lead Patent Ownership in Vaccine Packaging

5.2 IP Analysis Showcases High Patent Filing Activity in the United States

5.3 Material Classification and Key Innovation Themes under Intellectual Property Analysis

6.1 Acquisitions and Partnerships Expected to Expand Geographical Presence and Cater to Industrial Needs

6.2 Production Capacity Expansion Mainly Focused on Primary Pharmaceutical Packaging Applications

6.3 Product Launches Mainly Focused on Vaccine Storage and Packaging Materials

6.4 Researchers Exploring the Use of Nanocoated PS Glass Bottles for RNA-based Vaccines

6.5 Public and Private Funding Projects that Aim to Develop Alternative Materials

7.1 Plastic–glass Hybrid Vials for Storing COVID-19 Vaccines and Therapeutics

7.2 ULT Shipper Ensures High Thermal Stability for Temperature-sensitive mRNA Vaccines

7.3 Aluminosilicate Glass Formulation Eliminates the Risk of Delamination and Resists Cracks

7.4 Surfactant-stabilized Cellulose Matrix Materials Can Store Vaccines at Ambient and Elevated Temperatures

7.5 Fluoropolymer Foam Ensures Safe Transportation of Vaccine Requiring Ultra-cold Chain Support

7.6 Shipping Packaging Container with PCMs Designed for All Weather Conditions

7.7 Bio-based PCMs Offer Better Thermal Performance than Paraffin-based Materials

7.8 Recyclable and Compostable Vaccine-shipping Cooler Made from Plant-based Raw Materials

7.9 Sugar-based Biodegradable Polymer a Promising Alternative to Petroleum-based Secondary Packaging

7.10 Metal-free Syringes for Packaging Biotechnologically Manufactured Active Ingredients

7.11 Polymer Packaging Solution Protects COVID-19 Rapid Test Kits from Humidity and Oxygen

8.1 Growth Opportunity 1: Development of Conventional Borosilicate Alternatives for Primary Vaccine Packaging

8.1 Growth Opportunity 1: Development of Conventional Borosilicate Alternatives for Primary Vaccine Packaging (continued)

8.2 Growth Opportunity 2: Development of Biodegradable and Compostable Shipping Coolers for Secondary Packaging

8.2 Growth Opportunity 2: Development of Biodegradable and Compostable Shipping Coolers for Secondary Packaging (continued)

8.3 Growth Opportunity 3: Ultra-low Freezing Temperature Requirement for COVID-19 Vaccines Reshaping the Global Vaccine Cold Chain

8.3 Growth Opportunity 3: Ultra-low Freezing Temperature Requirement for COVID-19 Vaccines Reshaping the Global Vaccine Cold Chain (continued)

9.1 Technology Readiness Levels (TRL): Explanation

10.1 Your Next Steps

10.2 Why Frost, Why Now?

Legal Disclaimer